Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

The Global Deterioration Scale for assessment of primary degenerative dementia

Reisberg, ‌., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 5,122

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117

Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

GUNDERSEN, H. J. G., BENDTSEN, T. F., KORBO, L., MARCUSSEN, N., MØLLER, A., NIELSEN, K., NYENGAARD, J. R., PAKKENBERG, B., SØRENSEN, F. B., VESTERBY, A., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb05320.x · Cited by 2,929

The unbiased estimation of number and sizes of arbitrary particles using the disector

Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,533

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis

Gundersen, H. J. G., Bagger, P. V., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K. N., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,480

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

Kapogiannis, D., & Mattson, M. P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70277-5 · Cited by 594

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433

Lipid peroxidation and neurodegenerative disease

Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 385

Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies

Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365

The cell biology of synapse formation

Südhof, T. C. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202103052 · Cited by 358

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317

The cortical signature of prodromal AD

Bakkour, A., Morris, J. C., & Dickerson, B. C. (2008) · Neurology · doi:10.1212/01.wnl.0000340981.97664.2f · Cited by 321

Aging and Alzheimer's disease: comparison and associations from molecular to system level

Xia, X., Jiang, Q., McDermott, J., & Han, J. J. (2018) · Aging Cell · doi:10.1111/acel.12802 · Cited by 301

Synaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer's Disease

Scheff, S. W., PRICE, D. A., Schmitt, F. A., Scheff, M. A., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101782 · Cited by 305

Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease

Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 322

Piracetam and Piracetam-Like Drugs

Malykh, A., & Sadaie, M. R. (2010) · Drugs · doi:10.2165/11319230-000000000-00000 · Cited by 276

Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome

Hernández‐Ortega, K., Garcia‐Esparcia, P., Gil, L., Lucas, J. J., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12335 · Cited by 245

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F. (2010) · Brain · doi:10.1093/brain/awq258 · Cited by 230

4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies

Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229

Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways

Lee, C.-C., Huang, C., & Hsu, K. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.003 · Cited by 231

Insulin receptor signaling in the development of neuronal structure and function

Chiu, S., & Cline, H. T. (2010) · Neural Development · doi:10.1186/1749-8104-5-7 · Cited by 231

Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease

Leyhe, T., Müller, S., Milian, M., Eschweiler, G. W., & Saur, R. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.04.018 · Cited by 212

University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology

Schmitt, F. A., Nelson, P. T., Abner, E. L., Scheff, S. W., Jicha, G. A., Smith, C. D., Cooper, G. E., Mendiondo, M. S., Danner, D. D., Eldik, L. J. V., et al. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322591 · Cited by 185

Actin dynamics and cofilin‐actin rods in alzheimer disease

Bamburg, J. R., & Bernstein, B. W. (2016) · Cytoskeleton · doi:10.1002/cm.21282 · Cited by 181

DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice

Arsenault, D., Julien, C., Tremblay, C., & Calon, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017397 · Cited by 177

Multiple Defects in Energy Metabolism in Alzheimers Disease

Ferreira, I. L., Resende, R., Ferreiro, E. B., Rego, A. C., & Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 185

Hippocampal plasticity during the progression of Alzheimer’s disease

Mufson, E. J., Mahady, L. J., Waters, D., Counts, S., Perez, S. E., DeKosky, S. T., Ginsberg, S. D., Ikonomović, M. D., Scheff, S. W., & Binder, L. I. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.006 · Cited by 184

Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 171

Synaptic Change in the Posterior Cingulate Gyrus in the Progression of Alzheimer's Disease

Scheff, S. W., PRICE, D. A., Ansari, M. A., Roberts, K. N., Schmitt, F. A., Ikonomović, M. D., & Mufson, E. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141518 · Cited by 169

Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

Pocivavsek, A., Wu, H., Potter, M. C., Elmer, G. I., Pellicciari, R., & Schwarcz, R. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.127 · Cited by 171

AMPA receptors as drug targets in neurological disease—advantages, caveats, and future outlook

Chang, P. K. ‐., Verbich, D., & McKinney, R. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08165.x · Cited by 155

Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers

Ferreiro, E. B., Baldeiras, I., Ferreira, I. L., Costa, R. O., Rego, A. C., Pereira, C., & Oliveira, C. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/735206 · Cited by 156

Long-term cortisol measures predict Alzheimer disease risk

Ennis, G. E., An, Y., Resnick, S. M., Ferrucci, L., O'Brien, R. J., & Moffat, S. D. (2017) · Neurology · doi:10.1212/wnl.0000000000003537 · Cited by 151

Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders

Mottahedin, A., Ardalan, M., Chumak, T., Riebe, I., Ek, C. J., & Mallard, C. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00190 · Cited by 152

Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease

Chakroborty, S., Briggs, C. A., Miller, M. B., Goussakov, I. V., Schneider, C., Kim, J. S., Wicks, J. M., Richardson, J. C., Conklin, V., Cameransi, B. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052056 · Cited by 136

Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease

Magi, S., Castaldo, P., Macrì, M. L., Maiolino, M., Matteucci, A., Bastioli, G., Gratteri, S., Amoroso, S., & Lariccia, V. (2016) · BioMed Research International · doi:10.1155/2016/6701324 · Cited by 151

Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease

Edler, M. K., Sherwood, C. C., Meindl, R. S., Hopkins, W. D., Ely, J. J., ERWIN, J. M., Mufson, E. J., Hof, P. R., & Raghanti, M. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.006 · Cited by 138

The Role of Microglia in Synaptic Stripping and Synaptic Degeneration: A Revised Perspective

Perry, V. H., & O'Connor, V. M. (2010) · ASN NEURO · doi:10.1042/an20100024 · Cited by 131

NADPH-oxidase activation and cognition in Alzheimer disease progression

Ansari, M. A., & Scheff, S. W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.025 · Cited by 131

Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila

Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126

Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models

Subramanian, J., Savage, J. C., & Tremblay, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592607 · Cited by 127

Alzheimer 100 – highlights in the history of Alzheimer research

Jellinger, K. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0578-3 · Cited by 133

Is synaptic loss a unique hallmark of Alzheimer’s disease?

Scheff, S. W., Neltner, J. H., & Nelson, P. T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.028 · Cited by 118

Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease

Kazim, S. F., & Iqbal, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0119-y · Cited by 126

Endurance factors improve hippocampal neurogenesis and spatial memory in mice

Kobilo, T., Yuan, C., & van Praag, H. (2011) · Learning & Memory · doi:10.1101/lm.2001611 · Cited by 114

MicroRNA abundance is altered in synaptoneurosomes during prion disease

Boese, A. S., Saba, R., Campbell, K., Majer, A., Medina, S. J., Burton, L., Booth, T. F., Chong, P. M., Westmacott, G., Dutta, S. M., et al. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.12.001 · Cited by 116

First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates

Sankaranarayanan, S., Holahan, M. A., Colussi, D. J., Crouthamel, M., Devanarayan, V., Ellis, J. D., Espeseth, A. S., Gates, A. T., Graham, S. L., Gregro, A. R., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143628 · Cited by 107

miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

Barros-Viegas, A. T., Carmona, V., Ferreiro, E. B., Guedes, J. R., Cardoso, A. M., Cunha, P. S., de Almeida, L. P., Oliveira, C. R., Peça, J., Peça, J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.010 · Cited by 112

Evidence for Alzheimer’s disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons

Neuman, K. M., Molina-Campos, E., Musial, T. F., Price, A. L., Oh, K.-J., Wolke, M. L., Buss, E. W., Scheff, S. W., Mufson, E. J., & Nicholson, D. A. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0848-z · Cited by 104

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research

Bao, W., Xie, F., Zuo, C., Guan, Y., & Huang, Y. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624330 · Cited by 102

Regenerative potential of allopregnanolone

Wang, J. M., Liu, L., Irwin, R. W., Chen, S., & Brinton, R. D. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.08.010 · Cited by 103

Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer’s disease pathology

Scheff, S. W., Ansari, M. A., & Mufson, E. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.030 · Cited by 100

Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis

Jyoti, A., Sethi, P., & Sharma, D. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.11.011 · Cited by 96

DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effects

Perez, S. E., Berg, B. M., Moore, K. A., He, B., Counts, S., Fritz, J. J., Hu, Y., Lazarov, O., Lah, J. J., & Mufson, E. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22266 · Cited by 99

Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau

Dickstein, D. L., Brautigam, H., Stockton, S. D., Schmeidler, J., & Hof, P. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0245-1 · Cited by 99

Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 95

Human Brain/Cloud Interface

Martins, N. R. B., Angelica, A., Chakravarthy, K., Svidinenko, Y., Boehm, F. J., Opris, I., Lebedev, M. A., Swan, M., Garan, S. A., Rosenfeld, J. V., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00112 · Cited by 91

Structural Plasticity of the Hippocampus in Neurodegenerative Diseases

Weerasinghe-Mudiyanselage, P. D. E., Ang, M. J., Kang, S., Kim, J., & Moon, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063349 · Cited by 97

Structural networks in Alzheimer's disease

Reid, A., & Evans, A. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.11.010 · Cited by 94

Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer’s disease

Montero‐Crespo, M., Domínguez-Álvaro, M., Alonso‐Nanclares, L., DeFelipe, J., & Blázquez‐Llorca, L. (2020) · Brain · doi:10.1093/brain/awaa406 · Cited by 89

Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods

Phillips, D. J., McGlaughlin, A., Ruth, D. M., Jager, L. R., & Soldan, A. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.01.007 · Cited by 92

Emerging Link between Alzheimer’s Disease and Homeostatic Synaptic Plasticity

Jang, S.-S., & Chung, H. J. (2016) · Neural Plasticity · doi:10.1155/2016/7969272 · Cited by 93

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85

Aβ solubility and deposition during AD progression and in APP × PS-1 knock-in mice

Murphy, M. P., Beckett, T. L., Ding, Q., Patel, E., Markesbery, W. R., Clair, D. K. S., LeVine, H., & Keller, J. N. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.002 · Cited by 87

A Place at the Table

Connor, S. A., & Wang, Y. T. (2015) · The Neuroscientist · doi:10.1177/1073858415588498 · Cited by 92

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease

Farlow, M. R., Thompson, R. E., Wei, L., Tuchman, A. J., Grenier, E., Crockford, D., Wilke, S., Benison, J., & Alkon, D. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180759 · Cited by 85

Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness

Zakirova, Z., Tweed, M., Crynen, G. C., Reed, J. M., Abdullah, L. I., Nissanka, N., Mullan, M. A., MULLAN, M. J., Mathura, V. S., Crawford, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119579 · Cited by 83

Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model

LaClair, K. D., Donde, A., Ling, J. P., Jeong, Y. H., Chhabra, R., Martin, L. J., & Wong, P. C. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1637-y · Cited by 76

Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer’s Disease

Rudnitskaya, E. A., Muraleva, N. A., Maksimova, K. Y., Владимировна, К. Е., Kolosova, N. G., & Stefanova, N. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150161 · Cited by 82

Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients

Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., & Alonso-Nanclares, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0520-6 · Cited by 79

Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia

Wu, L., Cheah, I. K.-M., Chong, J. R., Chai, Y. L., Tan, J. Y., Hilal, S., Vrooman, H. A., Chen, C., Halliwell, B. B., & Lai, M. K. P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.019 · Cited by 82

Stress-Induced Cytokines and Neuronal Dysfunction in Alzheimer's Disease

Ricci, S., Fuso, A., Ippoliti, F., & Businaro, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110821 · Cited by 76

Trafficking in Alzheimer’s Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin

Eggert, S., Thomas, C., Kins, S., & Hermey, G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0806-x · Cited by 75

The prefrontal–limbic network in depression: A core pathology of synapse regression

Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.001 · Cited by 79

Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms

Du, Y., Qu, J., Zhang, W., Bai, M., Zhou, Q., Zhang, Z., Li, Z., & Miao, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.008 · Cited by 72

A plateau in pre-Alzheimer memory decline

Smith, G. E., Pankratz, V. S., Negash, S., Machulda, M. M., Petersen, R. C., Boeve, B. F., Knopman, D. S., Lucas, J. A., Ferman, T. J., Graff‐Radford, N. R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000265594.23511.16 · Cited by 71

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages

Poirel, O., Mella, S., Videau, C., Ramet, L., Davoli, M. A., Herzog, É., Katsel, P., Mechawar, N., Haroutunian, V. H., Epelbaum, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19154-y · Cited by 72

Mitochondrial retrograde signaling regulates neuronal function

Cagin, U., Duncan, O. F., Gatt, A. P., Dionne, M., Sweeney, S. T., & Bateman, J. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505036112 · Cited by 66

Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease

Kumari, P., Sood, A., & Fernandes, V. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01147-7 · Cited by 68

Treatment of Alzheimer’s Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions

Ashford, J. W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150381 · Cited by 66

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease

Ota, K., Oishi, N., Ito, K., & Fukuyama, H. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.08.020 · Cited by 68

Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis

Murray, P. S., Kirkwood, C. M., Gray, M. C., Fish, K. N., Ikonomović, M. D., Hamilton, R. L., Kofler, J., Klunk, W. E., López, O. L., & Sweet, R. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131166 · Cited by 67

The two faces of synaptic failure in AppNL-G-F knock-in mice

Latif‐Hernandez, A., Sabanov, V., Ahmed, T., Craessaerts, K., Saito, T., Saido, T. C., & Balschun, D. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00667-6 · Cited by 68

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease

Crespo‐Biel, N., Theunis, C., & LEUVEN, F. V. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/251426 · Cited by 69

Tetramethylpyrazine protects against scopolamine-induced memory impairments in rats by reversing the cAMP/PKA/CREB pathway

Wu, W., Yu, X., Luo, X., Yang, S., & Zheng, D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.052 · Cited by 61

Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment

Chen, P., Han, X., Shaw, T. I., Fu, Y., Sun, H., Niu, M., Wang, Z., Jiao, Y., Teubner, B. J. W., Eddins, D. M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00290-0 · Cited by 60

Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?

Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0466-z · Cited by 60

Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier

Kováč, A., Žilková, M., Deli, M. A., Žilka, N., & Novák, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1197 · Cited by 65

3D Electron Microscopy Study of Synaptic Organization of the Normal Human Transentorhinal Cortex and Its Possible Alterations in Alzheimer’s Disease

Domínguez-Álvaro, M., Montero‐Crespo, M., Blázquez‐Llorca, L., DeFelipe, J., & Alonso‐Nanclares, L. (2019) · eNeuro · doi:10.1523/eneuro.0140-19.2019 · Cited by 67

Synapse Stability in the Precuneus Early in the Progression of Alzheimer's Disease

Scheff, S. W., PRICE, D. A., Schmitt, F. A., Roberts, K. N., Ikonomović, M. D., & Mufson, E. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122353 · Cited by 60

The Pak1 Kinase: An Important Regulator of Neuronal Morphology and Function in the Developing Forebrain

Nikolić, M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8032-1 · Cited by 56

Mitochondria Are Related to Synaptic Pathology in Alzheimer′s Disease

Balogiannis, S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/305395 · Cited by 58

Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease

Ohm, D. T., Fought, A. J., Martersteck, A., Coventry, C., Sridhar, J., Gefen, T. D., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12902 · Cited by 59

β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis

Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomović, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J., Klunk, W. E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.015 · Cited by 58

Spatial training preserves associative memory capacity with augmentation of dendrite ramification and spine generation in Tg2576 mice

Jiang, X., Chai, G., Wang, Z.-H., Hu, Y., Li, X., Ma, Z., Wang, Q., Wang, J., & Liu, G. (2015) · Scientific Reports · doi:10.1038/srep09488 · Cited by 55

PET Imaging for Early Detection of Alzheimer’s Disease

Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 54

Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease

Buchanan, H. M., Mackay, M., PALMER, K., Tothová, K., Katsur, M., Platt, B., & Koss, D. J. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01950-1 · Cited by 58

Synaptic Compensatory Plasticity in Alzheimer’s Disease

Bhembre, N., Bonthron, C., & Opazo, P. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-23.2023 · Cited by 56

Neurodegenerative Diseases

Kim, S. E., Lee, J., & Song, Y. S. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0802-5_13 · Cited by 52

Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders

Ikonomović, M. D., Mi, Z., & Abrahamson, E. E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.003 · Cited by 53

Acute Kynurenine Challenge Disrupts Sleep–Wake Architecture and Impairs Contextual Memory in Adult Rats

Pocivavsek, A., Baratta, A. M., Mong, J. A., & Viechweg, S. S. (2017) · SLEEP · doi:10.1093/sleep/zsx141 · Cited by 50

Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies

Scheff, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.002 · Cited by 391

Synaptic Pathology in Dementia

Scheff, S. W. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0_30

Quantitative Assessment of Synaptic Density in the Outer Molecular Layer of the Hippocampal Dentate Gyrus in Alzheimer's Disease

Scheff, S. W., Sparks, D. L., & PRICE, D. A. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106884 · Cited by 95

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446

Neuronal Death versus Synaptic Pathology in Alzheimer's Disease

Bertoni–Freddari, C., Fattoretti, P., Solazzi, M., Giorgetti, B., Stefano, G. D., Casoli, T., & Meier-Ruge, W. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.116 · Cited by 30